Ghost Tree Capital’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Ghost Tree Capital’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,100,000	Closed	-$19.5M	–	66
2018 Q3	$19.5M	Buy	1,100,000 +600,000	+120%	+$10.3M	4.15%	5
2018 Q2	$6.9M	Sell	500,000 -1,700,000	-77%	-$20.2M	2.03%	18
2018 Q1	$20M	Buy	+2,200,000	New	+$12.1M	4.05%	4

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Ghost Tree Capital's ECYT Position: Q4 2018 in Review

Ghost Tree Capital sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 1,100,000 shares — an estimated $19.5M sold.

Ghost Tree Capital first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $20M in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Ghost Tree Capital reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Ghost Tree Capital sold 1,100,000 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $19.5M.
Ghost Tree Capital first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Ghost Tree Capital's Endocyte, Inc. Common Stock position peaked at $20M in Q1 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Ghost Tree Capital's 13F filing for Q4 2018, filed 14 Feb 2019.